Phase 3, Adolescent Large Scale Safety Study

Registry ID

EUCTR2009-015198-11

Source registry

EUCTR

Status

Completed

Phase

PHASE3

Sponsor

Pfizer Inc, 235 East 42nd Street, New York, NY 10017

Start date

2011-05-16

Completion date

2014-09-26

Last update

2026-08-16

Conditions

• Bacterial Meningitis
• Prevention of Bacterial Meningitis

Summary

To evaluate the safety of bivalent rLP2086 vaccine compared to a control (hepatitis A virus [HAV] vaccine/saline), as assessed by serious adverse events (SAEs) and medically attended adverse events.

Locations

• , , Spain
• , , Denmark
• , , Germany
• , , Sweden
• , , Finland
• , , Czechia
• , , Estonia
• , , Lithuania

Related clinical trials

• Acute Treatment and Long-term Assessment of Adult Infectious Meningitis
• Augmented Renal Clearance in Neurocritical Care
• Central Nervous System Infections in Denmark

View on source registry